Cargando…

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors

Detalles Bibliográficos
Autores principales: Govaerts, Inge, Jacobs, Kris, Vandepoel, Roel, Cools, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924561/
https://www.ncbi.nlm.nih.gov/pubmed/31976485
http://dx.doi.org/10.1097/HS9.0000000000000313
_version_ 1783481747011272704
author Govaerts, Inge
Jacobs, Kris
Vandepoel, Roel
Cools, Jan
author_facet Govaerts, Inge
Jacobs, Kris
Vandepoel, Roel
Cools, Jan
author_sort Govaerts, Inge
collection PubMed
description
format Online
Article
Text
id pubmed-6924561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69245612020-01-23 JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors Govaerts, Inge Jacobs, Kris Vandepoel, Roel Cools, Jan Hemasphere Letter Wolters Kluwer Health 2019-10-22 /pmc/articles/PMC6924561/ /pubmed/31976485 http://dx.doi.org/10.1097/HS9.0000000000000313 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Letter
Govaerts, Inge
Jacobs, Kris
Vandepoel, Roel
Cools, Jan
JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
title JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
title_full JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
title_fullStr JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
title_full_unstemmed JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
title_short JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
title_sort jak/stat pathway mutations in t-all, including the stat5b n642h mutation, are sensitive to jak1/jak3 inhibitors
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924561/
https://www.ncbi.nlm.nih.gov/pubmed/31976485
http://dx.doi.org/10.1097/HS9.0000000000000313
work_keys_str_mv AT govaertsinge jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors
AT jacobskris jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors
AT vandepoelroel jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors
AT coolsjan jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors